Adagrasib
id:
adagrasib-189-12054840
title:
Adagrasib
text:
Adagrasib, sold under the brand name Krazati, is an anticancer medication used to treat non-small cell lung cancer. Adagrasib is an inhibitor of G12C mutated KRAS GTPase. It is taken by mouth. It is being developed by Mirati Therapeutics. The most common adverse reactions include diarrhea, nausea, fatigue, vomiting, musculoskeletal pain, hepatotoxicity, renal impairment, dyspnea, edema, decreased appetite, cough, pneumonia, dizziness, constipation, abdominal pain, and QTc interval prolongation.
brand slug:
wiki
category slug:
encyclopedia
description:
Medication
original url:
https://en.wikipedia.org/wiki/Adagrasib
date created:
2021-03-07T06:08:04Z
date modified:
2024-09-09T20:10:14Z
main entity:
{"identifier":"Q105816120","url":"https://www.wikidata.org/entity/Q105816120"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/12/Adagrasib_structure.svg","width":512,"height":417}
fields total:
13
integrity:
16